Aziyo Biologics's total assets for Q1 2025 were $39.30M, an increase of 8.78% from the previous quarter. ELUT total liabilities were $75.76M for the fiscal quarter, a -8.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.